AUS
NZ
UK
CA
USA
IND
Healthcare
Could Viracta Therapeutics Drive a New Wave in Virus-Associated Cancer Care?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Viracta Therapeutics (NASDAQ:VIRX) operates in the precision oncology field.,The company is set to release quarterly financial updates on Thursday, March 6th.,Nana-val, an all-oral combination therapy, is progressing through clinical devel...
Is Xponential Fitness Embracing New Opportunities in the Boutique Fitness Sector?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Quarterly results are expected before the market opens on Thursday, March 6th,The company projects earnings per share of 0.39 and revenue of 81.12 million,The boutique fitness franchisor operates a diversified portfolio of recognizable bra...
Could This Biosimulation Provider Redefine Healthcare?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Certara (NASDAQ:CERT) is scheduled to release its next earnings figures after the market closes on Thursday, March 6th, with the figure for the period stated at 0.12 per share.,The company’s stock has moved within a 52-week range from 9.41...
Could This Biopharmaceutical Developer Advance Cancer Treatment?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Revenue goals for the upcoming announcement stand at 34.17 million.,Stock recently opened at 2.49 within a 52-week range from 2.34 to 21.88.,Scheduled earnings release is on March 6th.,MacroGenics, Inc. (NASDAQ:MGNX) operates within the bi...
Could Cartesian Therapeutics Transform Biotech Advancements?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Quarterly results expected at negative eighty cents per share, revenue near one-tenth of one million dollars,Shares opened around eighteen dollars, reflecting a market capitalization near four hundred fifty-eight million dollars,Lead pipel...
Is This E-Commerce Powerhouse Approaching a Key Turning Point?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Quarter results expected before the market opens on March 6,Earnings estimate is $0.90 per share with revenues reaching $332.70 billion,Stock opened recently at $42.53, reflecting upward momentum and strong liquidity measures,The e-commerc...
What Are the Key Insights from Akero Therapeutics' Latest Developments?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights:,Akero Therapeutics (NASDAQ:AKRO) is set to release its latest earnings report, with an anticipated loss per share of ($0.98) for the quarter.,The stock has seen notable price fluctuations, trading between $17.86 and $58.40 over the past y...
Which Emerging Biopharma Firm Excels in Oncology and Brain Treatments?
February 26, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,Distinctions in revenue and net earnings,Varying share figures and institutional support,Divergent therapy focuses: oncology versus brain health,Small-cap biopharmaceutical enterprises have drawn attention in the broader medical field by d...
Which Medical Device Companies Excel in Key Financial Metrics?
February 26, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,Escalon Medical (OTC:ESMC) shows a higher earnings per share compared to Micron Solutions (NYSE:MICR).,Micron Solutions posts a larger overall revenue figure than Escalon Medical.,Both companies present lower volatility levels compared to...
Will Genetic Testing Technologies Spark the Next Healthcare Breakthrough?
February 26, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,The company operates in specialized genetic offerings.,A negative net result contrasts with steady revenue figures.,Heightened volatility outpaces other organizations in its space.,Companies working on genetic testing have attracted widesp...
How Jazz Pharmaceuticals (NASDAQ:JAZZ) is Expanding its Global Footprint
February 26, 2025 10:00 AM PST| By Team Kalkine MediaHighlights,CIBC Asset Management and UMB Bank have boosted their stakes in Jazz Pharmaceuticals.,The company continues to grow its portfolio, addressing a range of medical needs.,Despite recent stock transactions, the company maintains favorable mark...
IQVIA Holdings (NYSE:IQV) A Look at Institutional Investments and Market Performance
February 26, 2025 09:55 AM PST| By Team Kalkine MediaHighlights,Major firms, including Sanctuary Advisors LLC and FMR LLC, have expanded their positions in IQVIA Holdings.,Recent earnings reports indicate a minor shortfall, yet the company maintains a strong market position.,Price targets have been adj...
How Has Arbutus Biopharma (NASDAQ:ABUS) Performed in the Market Recently
February 26, 2025 09:42 AM PST| By Team Kalkine MediaHighlights,Arbutus Biopharma has seen varying ratings from research firms, reflecting different market perspectives.,The company continues to maintain significant institutional interest, with firms adjusting their holdings.,Arbutus focuses on develop...
How Is Tempus AI (NASDAQ:TEM) Advancing Precision Medicine
February 26, 2025 09:30 AM PST| By Team Kalkine MediaHighlights,Tempus AI recorded higher trading volume following a price target adjustment by Needham & Company LLC.,Institutional ownership increased, now accounting for 24.22% of the company's total stock.,Tempus AI focuses on AI-powered precision me...
How Is SI-BONE (NASDAQ:SIBN) Expanding Its Presence in the Medical Device Sector
February 26, 2025 09:02 AM PST| By Team Kalkine MediaHighlights,SI-BONE reported earnings per share above expectations, contributing to increased market interest.,Institutional investors adjusted their holdings, reflecting engagement with the company.,The company continues to expand its presence in mus...
How Does Pyxis Oncology (NASDAQ:PYXS) Position Itself in Targeted Cancer Therapy
February 26, 2025 09:00 AM PST| By Team Kalkine MediaHighlights,Institutional investors have modified their holdings in Pyxis Oncology, reflecting active market engagement.,The company continues to advance its pipeline of cancer therapeutics, focusing on targeted treatments.,Stock performance has shown...
How Is Inari Medical Inc. (NASDAQ:NARI) Advancing Thrombectomy Treatments
February 26, 2025 08:56 AM PST| By Team Kalkine MediaHighlights,Institutional investors have adjusted their stakes in Inari Medical, contributing to market engagement.,The company maintains a structured financial approach, with stable revenue figures.,Inari Medical focuses on innovative medical solutio...
Merck & Co., Inc. (MRK): Key Asset in Bourgeon Capital's Portfolio
February 26, 2025 08:36 AM PST| By Team Kalkine MediaHighlights,Merck & Co., Inc.,(NYSE:MRK),is a leading player in the pharmaceutical sector, contributing significantly to Bourgeon Capital's portfolio.,The company is recognized for its extensive product line, including vaccines and oncology treatments...
How Elanco Animal Health (NYSE:ELAN) Responded to Market Pressure Following Q4 Results
February 26, 2025 08:34 AM PST| By Team Kalkine MediaHighlights,Elanco Animal Health reported a miss in earnings, with EPS falling short of expectations.,Analysts adjusted their price targets and ratings, showing mixed sentiment.,Institutional investors have continued to adjust their positions, with so...
Acadia Healthcare (NASDAQ: ACHC) The Influence of Institutional Investors on Its Stock
February 26, 2025 08:15 AM PST| By Team Kalkine MediaHighlights,Rhumbline Advisers raised its stake in Acadia Healthcare by 4.6%.,Notable institutional players like Wellington Management and JPMorgan Chase expanded their holdings.,Acadia Healthcare continues to provide crucial behavioral health service...
